Market revenue in 2024 | USD 735.9 million |
Market revenue in 2030 | USD 1,034.5 million |
Growth rate | 5.8% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.59% in 2024. Horizon Databook has segmented the Latin America infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America includes Brazil, Mexico, and Argentina. Technological developments are expected to contribute to market growth. In addition, increase in government spending, rising number of skilled healthcare professionals, rise in focus of multinational diagnostic companies on development of advanced & novel infectious diseases molecular diagnostics are likely to drive growth of infectious diseases molecular diagnostics market in Latin America.
Low awareness about the prevention & treatment of infectious diseases in undeveloped areas, high cost of treatment, and the lack of favorable reimbursement policies are some of the key factors restraining market growth.
However, a slow rise in disposable income and growing consumer awareness are a few factors promoting growth. Latin America is expected to grow at a healthy rate owing to government initiatives on regulations and reimbursement of lab tests and trials.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America infectious disease molecular diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account